276 related articles for article (PubMed ID: 19536308)
1. Vascular endothelial growth factor upregulates expression of annexin A2 in vitro and in a mouse model of ischemic retinopathy.
Zhao S; Huang L; Wu J; Zhang Y; Pan D; Liu X
Mol Vis; 2009 Jun; 15():1231-42. PubMed ID: 19536308
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor upregulates expression of ADAMTS1 in endothelial cells through protein kinase C signaling.
Xu Z; Yu Y; Duh EJ
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4059-66. PubMed ID: 16936124
[TBL] [Abstract][Full Text] [Related]
3. Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization.
Shen J; Yang X; Xiao WH; Hackett SF; Sato Y; Campochiaro PA
FASEB J; 2006 Apr; 20(6):723-5. PubMed ID: 16473886
[TBL] [Abstract][Full Text] [Related]
4. [The expression and function of annexin A2 in the course of retinal angiogenesis of mouse].
Wang M; Yang X; Dong XG
Zhonghua Yan Ke Za Zhi; 2013 Jul; 49(7):642-8. PubMed ID: 24257362
[TBL] [Abstract][Full Text] [Related]
5. Agents that bind annexin A2 suppress ocular neovascularization.
Lima e Silva R; Shen J; Gong YY; Seidel CP; Hackett SF; Kesavan K; Jacoby DB; Campochiaro PA
J Cell Physiol; 2010 Nov; 225(3):855-64. PubMed ID: 20607799
[TBL] [Abstract][Full Text] [Related]
6. EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown.
Ojima T; Takagi H; Suzuma K; Oh H; Suzuma I; Ohashi H; Watanabe D; Suganami E; Murakami T; Kurimoto M; Honda Y; Yoshimura N
Am J Pathol; 2006 Jan; 168(1):331-9. PubMed ID: 16400034
[TBL] [Abstract][Full Text] [Related]
7. Suppression of transient receptor potential canonical channel 4 inhibits vascular endothelial growth factor-induced retinal neovascularization.
Song HB; Jun HO; Kim JH; Fruttiger M; Kim JH
Cell Calcium; 2015 Feb; 57(2):101-8. PubMed ID: 25605522
[TBL] [Abstract][Full Text] [Related]
8. Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity.
Wang H; Yang Z; Jiang Y; Hartnett ME
Mol Vis; 2014; 20():231-41. PubMed ID: 24623966
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy.
Al-Shabrawey M; Bartoli M; El-Remessy AB; Platt DH; Matragoon S; Behzadian MA; Caldwell RW; Caldwell RB
Am J Pathol; 2005 Aug; 167(2):599-607. PubMed ID: 16049343
[TBL] [Abstract][Full Text] [Related]
10. Expression of thrombospondin-1 in ischemia-induced retinal neovascularization.
Suzuma K; Takagi H; Otani A; Oh H; Honda Y
Am J Pathol; 1999 Feb; 154(2):343-54. PubMed ID: 10027393
[TBL] [Abstract][Full Text] [Related]
11. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization.
Takagi H; Koyama S; Seike H; Oh H; Otani A; Matsumura M; Honda Y
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):393-402. PubMed ID: 12506101
[TBL] [Abstract][Full Text] [Related]
12. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
13. Blockade of Annexin A2 Prevents Early Microvasculopathy in Murine Models of Diabetic Retinopathy.
Dallacasagrande V; Liu W; Almeida D; Luo M; Hajjar KA
Invest Ophthalmol Vis Sci; 2023 Apr; 64(4):33. PubMed ID: 37103008
[TBL] [Abstract][Full Text] [Related]
14. An apelin receptor antagonist prevents pathological retinal angiogenesis with ischemic retinopathy in mice.
Ishimaru Y; Shibagaki F; Yamamuro A; Yoshioka Y; Maeda S
Sci Rep; 2017 Nov; 7(1):15062. PubMed ID: 29118394
[TBL] [Abstract][Full Text] [Related]
15. Annexin A2 promotes choroidal neovascularization by increasing vascular endothelial growth factor expression in a rat model of argon laser coagulation-induced choroidal neovascularization.
Zhao SH; Pan DY; Zhang Y; Wu JH; Liu X; Xu Y
Chin Med J (Engl); 2010 Mar; 123(6):713-21. PubMed ID: 20368092
[TBL] [Abstract][Full Text] [Related]
16. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin.
Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L
Elife; 2020 Apr; 9():. PubMed ID: 32312382
[TBL] [Abstract][Full Text] [Related]
17. Ephrin-a4 is involved in retinal neovascularization by regulating the VEGF signaling pathway.
Du W; Yu W; Huang L; Zhao M; Li X
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):1990-8. PubMed ID: 22408005
[TBL] [Abstract][Full Text] [Related]
18. Response of experimental retinal neovascularization to thiazolidinediones.
Murata T; Hata Y; Ishibashi T; Kim S; Hsueh WA; Law RE; Hinton DR
Arch Ophthalmol; 2001 May; 119(5):709-17. PubMed ID: 11346398
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity.
Geisen P; Peterson LJ; Martiniuk D; Uppal A; Saito Y; Hartnett ME
Mol Vis; 2008 Feb; 14():345-57. PubMed ID: 18334951
[TBL] [Abstract][Full Text] [Related]
20. Targeting of integrin-linked kinase with small interfering RNA inhibits VEGF-induced angiogenesis in retinal endothelial cells.
Xie W; Zhao M; Zhou W; Guo L; Huang L; Yu W; Li X
Ophthalmic Res; 2013; 49(3):139-49. PubMed ID: 23258222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]